BioSpace News Archive

BioCapital

AACC-Led Effort Culminates in an Additional $2 Million for CDC

Omnibus Bill Funding Will Support Program to Ensure Uniformity Among Medical Lab Tests

March 23, 2018
·
3 min read
Business

CBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 Antibody

Crown Bioscience and a global drug discovery and development services company announced a strategic licensing agreement with CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company.

March 23, 2018
·
3 min read
Deals

GSK Walks Away From Acquiring Pfizer Consumer Goods Unit

GlaxoSmithKline has decided not to make a play for Pfizer’s consumer health business. The decision came one day after another potential suitor walked away from a potential deal.

March 23, 2018
·
2 min read
·
Alex Keown
Drug Development

Novartis Published Multiple Sclerosis Trial Data With Plans to File for FDA Approval

Novartis released full results from its Phase III EXPAND trial of siponimod (BAF312) in secondary progressive multiple sclerosis (SPMS), which it published in the journal The Lancet.

March 23, 2018
·
2 min read
·
Mark Terry
Deals

Akebia Announces $85M Public Offering

Akebia Therapeutics, a kidney disease company, announced plans to offer and sell about $85 million of its common stock in an underwritten public offering.

March 23, 2018
·
2 min read
·
Mark Terry
German Biotech MorphoSys Seeks Nasdaq Listing

MorphoSys, a Germany-based biopharmaceutical company, is aiming for a listing on the Nasdaq exchange hoping to secure approximately $150 million.

March 23, 2018
·
2 min read
·
Alex Keown
Job Trends

Pharma Execs are Attractive Candidates for Healthcare Leadership Roles

Healthcare companies are now looking at pharma executives for leadership roles as the landscape of healthcare is dramatically changing.

March 23, 2018
·
2 min read
·
Alex Keown